Developer docs
API playgroundTry for free, no card

Search company profiles

University Compound Pharmacy

Full company profile

uuid0006dj4

Namestring
University Compound Pharmacy
Legal namestring
University Compounding Pharmacy
Websiteurl
ucprx.com
Company typeenum
Private
Founded yearint
1993
Descriptiontext

University Compounding Pharmacy (UCP) is a 503A compounding pharmacy founded in 1993 in San Diego, California, by brothers John and Joe Grasela. The company specializes in patient-specific compounded medications for cases where standard commercial drugs are unsuitable due to dosage, formulation, allergy, or availability constraints. Its core product lines span urology (Tri-Mix, Bi-Mix, and Quad-Mix penile injections, urethral gel, vacuum erection devices, and the C. Lowell Parsons interstitial cystitis bladder instillation formula), bio-identical hormone replacement therapy (estradiol, progesterone, testosterone, DHEA in transdermal, vaginal, sublingual, and oral forms), ophthalmology (compounded Vancomycin and fortified Tobramycin eye drops), weight loss (compounded Semaglutide and Tirzepatide), growth-hormone support (Secretropin), and ancillary services such as generic sildenafil distribution and certified nutritionist consultations. All sterile preparations are compounded in a PCAB-accredited facility with an ISO Class 7 clean room and a 17-formula sterile library tested by an independent analytical laboratory.

UCP operates a sales-led, physician-prescribed distribution model: licensed prescribers submit patient-specific prescriptions via phone, fax, e-prescription, or secure email, and the pharmacy contacts patients directly, confirms orders, and ships overnight via FedEx/USPS in temperature-controlled packaging to 46 U.S. states. Revenue is generated through one-time per-prescription dispensing with refill-driven recurring volume, supplemented by hardware sales (vacuum devices) and professional services (nutritionist consultations). The company employs 101-250 staff, including 10 highly skilled compounding pharmacists overseeing the labs and dispensing function, and has educated an estimated 50,000 physicians through its founder-led medical education program.

In September 2025, Belgian-headquartered global pharmaceutical compounding leader Fagron announced the acquisition of UCP at an enterprise value of approximately $41.5 million against annual revenues of approximately $25 million, with completion on January 12, 2026. UCP now operates as a wholly-owned subsidiary within Fagron's nationwide 503A/503B compounding platform, with expected integration synergies over an 18-24 month period.

Short descriptiontext

University Compounding Pharmacy is a 503A compounding pharmacy founded in 1993 in San Diego, providing patient-specific compounded medications across urology, BHRT, ophthalmology, and weight loss to patients in 46 U.S. states under physician prescriptions, now operating as a subsidiary of Fagron.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
compounding pharmacy, sterile injectable medications, bio-identical hormone therapy, urological compounded treatments, patient-specific prescriptions
Industry1 code
PRIMARYHLAFALAE
Compounding Pharmacies (Sterile/Non-Sterile)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing3254
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Compounding Pharmacy Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Compounded Prescriptions
TypeOne Time License
Description

Patient-specific compounded medications dispensed pursuant to valid prescriptions. Includes sterile injectables, topical preparations, bio-identical hormones, urological compounds, and ophthalmology preparations. Revenue generated through prescription fulfillment with recurring refill opportunities.

ucprx.com
2Generic Pharmaceuticals
TypeOne Time License
Description

Distribution of FDA-approved generic medications including generic Viagra (Sildenafil) in 25mg, 50mg, and 100mg strengths at discounted prices.

ucprx.com
3Medical Devices
TypeHardware Sales
Description

Vacuum erection therapy devices sold to patients, with insurance billing handled by the pharmacy. Devices include battery and manual options with accessories.

ucprx.com
4Nutrition Services
TypeProfessional Services
Description

Consultation services with certified nutritionist Kim Ruby, BS, CN for weight loss, heart healthy diets, anti-aging, and gluten-free living.

ucprx.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1Secretropin®
Description

A Non-Peptide Advanced Amino Acid Secretagogue with Nanoliposomal Delivery System.

ucprx.com
Core offering1 text field

University Compounding Pharmacy is a 503A compounding pharmacy that prepares patient-specific customized medications—including sterile injections, bio-identical hormones, urological compounds, compounded ophthalmology drops, and weight-loss therapies—dispensed pursuant to valid prescriptions from licensed physicians. The pharmacy operates an ISO Class 7 clean room, PCAB-accredited sterile and non-sterile laboratories, and ships prescriptions overnight to 46 U.S. states with an average 24-hour turnaround.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 24-hour average prescription turnaround
+3 more records
Product overview1 text field

University Compounding Pharmacy (UCP) is a specialized 503A compounding pharmacy founded in 1993, based in San Diego, California. The company operates as a single unified pharmacy offering with multiple therapeutic product lines centered on personalized compounding services. The core offerings include Tri-Mix Injection, Urethral Gel, Bio-identical Hormone Replacement Therapy (BHRT), Vacuum Erection Therapy, Generic Viagra, Interstitial Cystitis treatments, Semaglutide & Tirzepatide, Secretropin, Compounded Eye Drops, and Nutrition Services. UCP maintains an ISO Class 7 clean room for sterile preparations and offers both non-sterile and sterile compounding across these therapeutic areas, with overnight delivery available in 46 states. The pharmacy primarily serves patients through healthcare provider prescriptions, with a focus on personalized medications when standard options don't meet patient needs.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-12
Description

Belgian-headquartered global leader in pharmaceutical compounding. Completed acquisition of University Compounding Pharmacy in January 2026 with enterprise value of approximately $41.5 million. Acquisition strengthens Fagron's nationwide compounding platform in the United States spanning both 503A and 503B services. Expected synergies over 18-24 months integration period.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Regional 503A compounding pharmacy in the Southeast offering bio-identical hormones, thyroid, and urological preparations. Comparable therapeutic mix and physician-prescribed GTM to UCP at smaller scale.

TypeDirect peer
Description

FDA-registered 503B outsourcing facility producing sterile preparations for hospitals and clinics. Comparable in sterile compounding expertise though 503B-focused versus UCP's 503A model.

3Triangle Compounding Pharmacy
TypeDirect peer
Description

PCAB-accredited compounding pharmacy offering sterile and non-sterile preparations, BHRT, urologicals, and pain management formulations. Competes with UCP in the same patient-prescriber workflow model.

TypeDirect peer
Description

Independent 503A compounding pharmacy with sterile cleanroom operations serving multiple therapeutic areas. Comparable in compounding scope and physician-prescribed distribution.

5Kelley-Ross Compounding Pharmacy
TypeDirect peer
Description

Seattle-based PCAB-accredited compounding pharmacy offering sterile and non-sterile preparations, hormone, and ophthalmology compounds. Comparable compounding categories and patient-physician service model.

6Professional Compounding Centers of America (PCCA)
TypeOthers
Description

Supplier of APIs, bases, and equipment to independent compounding pharmacies like UCP. Adjacent rather than competitive; provides infrastructure and training that UCP relies on for its compounding operations.

TypeBroad incumbent
Description

National pharmacy chain offering limited compounding services alongside broad retail and specialty pharmacy operations. Indirectly comparable as a distribution channel for personalized medications at much larger scale.

8Wedgewood Pharmacy
TypeDirect peer
Description

One of the largest U.S. compounding pharmacies serving both human and veterinary patients with sterile and non-sterile preparations. Comparable to UCP in PCAB-accredited compounding, nationwide shipping, and a broad proprietary formulary.

TypeDirect peer
Description

Large Texas-based 503A/503B compounder offering sterile injectables, hormone replacement, and weight-loss therapies with nationwide distribution. Directly comparable product mix and regulatory posture to UCP.

TypeOthers
Description

Wholesale distributor of compounding chemicals, APIs, and supplies to compounding pharmacies including UCP. Comparable as an enabling infrastructure provider in the 503A compounding ecosystem.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

University Compound Pharmacy

Compounding Pharmacy Servicesucprx.com

University Compounding Pharmacy is a 503A compounding pharmacy founded in 1993 in San Diego, providing patient-specific compounded medications across urology, BHRT, ophthalmology, and weight loss to patients in 46 U.S. states under physician prescriptions, now operating as a subsidiary of Fagron.

What University Compound Pharmacy does

University Compounding Pharmacy (UCP) is a 503A compounding pharmacy founded in 1993 in San Diego, California, by brothers John and Joe Grasela. The company specializes in patient-specific compounded medications for cases where standard commercial drugs are unsuitable due to dosage, formulation, allergy, or availability constraints. Its core product lines span urology (Tri-Mix, Bi-Mix, and Quad-Mix penile injections, urethral gel, vacuum erection devices, and the C. Lowell Parsons interstitial cystitis bladder instillation formula), bio-identical hormone replacement therapy (estradiol, progesterone, testosterone, DHEA in transdermal, vaginal, sublingual, and oral forms), ophthalmology (compounded Vancomycin and fortified Tobramycin eye drops), weight loss (compounded Semaglutide and Tirzepatide), growth-hormone support (Secretropin), and ancillary services such as generic sildenafil distribution and certified nutritionist consultations. All sterile preparations are compounded in a PCAB-accredited facility with an ISO Class 7 clean room and a 17-formula sterile library tested by an independent analytical laboratory.

UCP operates a sales-led, physician-prescribed distribution model: licensed prescribers submit patient-specific prescriptions via phone, fax, e-prescription, or secure email, and the pharmacy contacts patients directly, confirms orders, and ships overnight via FedEx/USPS in temperature-controlled packaging to 46 U.S. states. Revenue is generated through one-time per-prescription dispensing with refill-driven recurring volume, supplemented by hardware sales (vacuum devices) and professional services (nutritionist consultations). The company employs 101-250 staff, including 10 highly skilled compounding pharmacists overseeing the labs and dispensing function, and has educated an estimated 50,000 physicians through its founder-led medical education program.

In September 2025, Belgian-headquartered global pharmaceutical compounding leader Fagron announced the acquisition of UCP at an enterprise value of approximately $41.5 million against annual revenues of approximately $25 million, with completion on January 12, 2026. UCP now operates as a wholly-owned subsidiary within Fagron's nationwide 503A/503B compounding platform, with expected integration synergies over an 18-24 month period.

University Compound Pharmacy firmographics

Firmographics
Name
University Compound Pharmacy
Legal name
University Compounding Pharmacy
Website
https://ucprx.com
Company type
Private
Founded year
1993
Operating status
Acquired
Headcount range
11–50 employees
Short description
University Compounding Pharmacy is a 503A compounding pharmacy founded in 1993 in San Diego, providing patient-specific compounded medications across urology, BHRT, ophthalmology, and weight loss to patients in 46 U.S. states under physician prescriptions, now operating as a subsidiary of Fagron.
Ownership category
akta.pro rank

University Compound Pharmacy industry classification

Industry
Product category
Compounding Pharmacy Services
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAFALAE
Compounding Pharmacies (Sterile/Non-Sterile)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services

Keywords

  • Compounding pharmacy
  • Sterile injectable medications
  • Bio-identical hormone therapy
  • Urological compounded treatments
  • Patient-specific prescriptions

Where University Compound Pharmacy is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices1 record

Markets served

University Compound Pharmacy business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Compounded Prescriptions: Patient-specific compounded medications dispensed pursuant to valid prescriptions. Includes sterile injectables, topical preparations, bio-identical hormones, urological compounds, and ophthalmology preparations. Revenue generated through prescription fulfillment with recurring refill opportunities.
  2. Generic Pharmaceuticals: Distribution of FDA-approved generic medications including generic Viagra (Sildenafil) in 25mg, 50mg, and 100mg strengths at discounted prices.
  3. Medical Devices: Vacuum erection therapy devices sold to patients, with insurance billing handled by the pharmacy. Devices include battery and manual options with accessories.
  4. Nutrition Services: Consultation services with certified nutritionist Kim Ruby, BS, CN for weight loss, heart healthy diets, anti-aging, and gluten-free living.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

University Compound Pharmacy product offering

Product offering

Core offering

University Compounding Pharmacy is a 503A compounding pharmacy that prepares patient-specific customized medications—including sterile injections, bio-identical hormones, urological compounds, compounded ophthalmology drops, and weight-loss therapies—dispensed pursuant to valid prescriptions from licensed physicians. The pharmacy operates an ISO Class 7 clean room, PCAB-accredited sterile and non-sterile laboratories, and ships prescriptions overnight to 46 U.S. states with an average 24-hour turnaround.

Product overview

University Compounding Pharmacy (UCP) is a specialized 503A compounding pharmacy founded in 1993, based in San Diego, California. The company operates as a single unified pharmacy offering with multiple therapeutic product lines centered on personalized compounding services. The core offerings include Tri-Mix Injection, Urethral Gel, Bio-identical Hormone Replacement Therapy (BHRT), Vacuum Erection Therapy, Generic Viagra, Interstitial Cystitis treatments, Semaglutide & Tirzepatide, Secretropin, Compounded Eye Drops, and Nutrition Services. UCP maintains an ISO Class 7 clean room for sterile preparations and offers both non-sterile and sterile compounding across these therapeutic areas, with overnight delivery available in 46 states. The pharmacy primarily serves patients through healthcare provider prescriptions, with a focus on personalized medications when standard options don't meet patient needs.

Differentiator

Problem solved

Functional benefit

Brands

  • Secretropin®: A Non-Peptide Advanced Amino Acid Secretagogue with Nanoliposomal Delivery System.

Quantifiable outcome

  • 24-hour average prescription turnaround
  • +3 more outcomes

Companies that use University Compound Pharmacy

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles2 records

University Compound Pharmacy technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

University Compound Pharmacy partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • FagroncoreStrategic or Co-development Partner · 12 January 2026Belgian-headquartered global leader in pharmaceutical compounding. Completed acquisition of University Compounding Pharmacy in January 2026 with enterprise value of approximately $41.5 million. Acquisition strengthens Fagron's nationwide compounding platform in the United States spanning both 503A and 503B services. Expected synergies over 18-24 months integration period.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

University Compound Pharmacy competitors and assessment

Company assessment

Direct peers

  • Pavilion Compounding Pharmacy: Regional 503A compounding pharmacy in the Southeast offering bio-identical hormones, thyroid, and urological preparations. Comparable therapeutic mix and physician-prescribed GTM to UCP at smaller scale.
  • Leiters: FDA-registered 503B outsourcing facility producing sterile preparations for hospitals and clinics. Comparable in sterile compounding expertise though 503B-focused versus UCP's 503A model.
  • Triangle Compounding Pharmacy: PCAB-accredited compounding pharmacy offering sterile and non-sterile preparations, BHRT, urologicals, and pain management formulations. Competes with UCP in the same patient-prescriber workflow model.
  • Reed's Compounding Pharmacy: Independent 503A compounding pharmacy with sterile cleanroom operations serving multiple therapeutic areas. Comparable in compounding scope and physician-prescribed distribution.
  • Kelley-Ross Compounding Pharmacy: Seattle-based PCAB-accredited compounding pharmacy offering sterile and non-sterile preparations, hormone, and ophthalmology compounds. Comparable compounding categories and patient-physician service model.
  • Wedgewood Pharmacy: One of the largest U.S. compounding pharmacies serving both human and veterinary patients with sterile and non-sterile preparations. Comparable to UCP in PCAB-accredited compounding, nationwide shipping, and a broad proprietary formulary.
  • Empower Pharmacy: Large Texas-based 503A/503B compounder offering sterile injectables, hormone replacement, and weight-loss therapies with nationwide distribution. Directly comparable product mix and regulatory posture to UCP.

Others

  • Professional Compounding Centers of America (PCCA): Supplier of APIs, bases, and equipment to independent compounding pharmacies like UCP. Adjacent rather than competitive; provides infrastructure and training that UCP relies on for its compounding operations.
  • Letco Medical: Wholesale distributor of compounding chemicals, APIs, and supplies to compounding pharmacies including UCP. Comparable as an enabling infrastructure provider in the 503A compounding ecosystem.

Broad incumbents

  • Walgreens Specialty Pharmacy: National pharmacy chain offering limited compounding services alongside broad retail and specialty pharmacy operations. Indirectly comparable as a distribution channel for personalized medications at much larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

University Compound Pharmacy social profiles

Digital presence

University Compound Pharmacy compliance and trust

Trust signal

Compliance2 records

University Compound Pharmacy financial estimates

Financial estimate

Revenue estimate

Valuation estimate

University Compound Pharmacy leadership team

Management profile

Number of profiles

Profiles1 record

University Compound Pharmacy funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

University Compound Pharmacy M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University Compound Pharmacy

What does University Compound Pharmacy do?

University Compounding Pharmacy is a 503A compounding pharmacy that prepares patient-specific customized medications—including sterile injections, bio-identical hormones, urological compounds, compounded ophthalmology drops, and weight-loss therapies—dispensed pursuant to valid prescriptions from licensed physicians. The pharmacy operates an ISO Class 7 clean room, PCAB-accredited sterile and non-sterile laboratories, and ships prescriptions overnight to 46 U.S. states with an average 24-hour turnaround.

Is University Compound Pharmacy a public or private company?

University Compound Pharmacy is a private company. It is classified as corporate owned and is currently acquired.

When was University Compound Pharmacy founded?

University Compound Pharmacy was founded in 1993. It employs 11 to 50 people.

Where is University Compound Pharmacy based?

University Compound Pharmacy is headquartered in San Diego, United States, in the North America region.

How does University Compound Pharmacy make money?

Four revenue lines are on record. Compounded Prescriptions are the primary driver. The others are generic Pharmaceuticals, medical Devices and nutrition Services.

Who are University Compound Pharmacy's main competitors?

Direct peers on record are Pavilion Compounding Pharmacy, Leiters, Triangle Compounding Pharmacy, Reed's Compounding Pharmacy, Kelley-Ross Compounding Pharmacy, Wedgewood Pharmacy and Empower Pharmacy. Others are Professional Compounding Centers of America (PCCA) and Letco Medical. Walgreens Specialty Pharmacy is listed as a broad incumbent.

Does University Compound Pharmacy have an API?

No public API is recorded for University Compound Pharmacy.

What industry is University Compound Pharmacy in?

University Compound Pharmacy's product category is Compounding Pharmacy Services. Its primary akta.pro industry code is HLAFALAE, Compounding Pharmacies (Sterile/Non-Sterile). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals